February 20, 2020

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

• Gao et al. report that Chloroquine phosphate (an antimalarial drug) has apparent efficacy in treatment of COVID-19 associated pneumonia in multicenter clinical trial studies in China. The drug is now recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission.

Gao et al. (Feb 19, 2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends. https://doi.org/10.5582/bst.2020.01047